Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bionano Genomics Inc. (BNGO)

2.55   0.01 (0.39%) 01-16 05:45
Open: 2.5164 Pre. Close: 2.54
High: 2.615 Low: 2.4309
Volume: 6,797,509 Market Cap: 737M
Bionano Genomics, Inc., a genome analysis company, provides tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. Its Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables scientists and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. The company also provides diagnostic testing for those with autism spectrum disorder and other neurodevelopmental disabilities. In addition, it offers an agnostic cross-platform data interpretation and clinical reporting software that integrates next-generation sequencing and microarray data, and provides visualization of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome for a fully integrated analysis in one view. The company was founded in 2006 and is headquartered in San Diego, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.622 - 2.634 2.634 - 2.646
Low: 2.4 - 2.413 2.413 - 2.426
Close: 2.527 - 2.549 2.549 - 2.57

Technical analysis

as of: 2022-01-15 8:44:55 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.70     One year: 4.23
Support: Support1: 2.43    Support2: 2.02
Resistance: Resistance1: 3.17    Resistance2: 3.62
Pivot: 2.90
Moving Average: MA(5): 2.66     MA(20): 2.99
MA(100): 4.56     MA(250): 6.38
MACD: MACD(12,26): -0.30     Signal(9): -0.30
Stochastic oscillator: %K(14,3): 11.62     %D(3): 14.09
RSI: RSI(14): 29.50
52-week: High: 15.69  Low: 2.43  Change(%): -69.2
Average Vol(K): 3-Month: 921154  10-Days: 881062

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BNGO has closed above bottom band by 12.9%. Bollinger Bands are 8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 13 Jan 2022
Bionano Genomics Hosts Final Day of 2022 Symposium with Presentations Demonstrating the Combined Detection Power of OGM and NGS - Yahoo Finance

Wed, 12 Jan 2022
Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2021 Results - Yahoo Finance

Mon, 10 Jan 2022
Bionano Genomics Announces Publication Of Interim Readout From Consortium Conducting Postnatal Clinical Trial Intended To Support Establishing Optical Genome Mapping As Part Of Standard Of Care In Genetic Disease Diagnosis - Benzinga

Wed, 29 Dec 2021
Thinking about buying stock in TMC The Metals Company, Cal-Maine Foods, FuelCell Energy, Vaxart, or BioNano Genomics? - PRNewswire

Thu, 23 Dec 2021
University Hospitals Leuven in Belgium Outlines their Menu - GlobeNewswire

Wed, 22 Dec 2021
Bionano Genomics Appoints Vince Wong to its Board of Directors - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 289
Shares Float (M) 283
% Held by Insiders 2.17
% Held by Institutions 25.64
Shares Short (K) 40,520
Shares Short P. Month (K) 40,170

Stock Financials

EPS -0.250
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.210
Profit Margin
Operating Margin -369.80
Return on Assets (ttm) -18.1
Return on Equity (ttm) -34.4
Qtrly Rev. Growth 112.0
Gross Profit (p.s.) 0.010
Sales Per Share 0.054
EBITDA (p.s.) -0.193
Qtrly Earnings Growth
Operating Cash Flow (M) -58
Levered Free Cash Flow (M) -28

Stock Valuations

PE Ratio -10.20
PEG Ratio
Price to Book value 2.11
Price to Sales 47.06
Price to Cash Flow -12.62

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.